Alyftrek 10-50-125 MG tablet 14S
Ended Awarded Last action
- Contract number
- SPE2DR26FQWM1
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $107,125
Award facts
- Contract value 100% obligated
- $107,125.15 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $107,125.15 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for ALYFTREK 10-50-125 mg tablets (14-unit packages). The award, issued on January 27, 2026, with an ultimate completion date of January 28, 2026, was made without set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This delivery order falls under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion government-wide acquisition strategy with a contract ceiling of $499,999,999 through December 31, 2036.
DMS Pharmaceutical Group Inc. serves as a critical regional pharmaceutical supplier for Department of Defense healthcare operations, distributing a comprehensive range of prescription medications, biologics, vaccines, and medical consumables to military medical facilities. The company's established performance on numerous delivery orders under the PPV-G GEN V contract demonstrates its capability to fulfill specialized pharmaceutical requirements across the federal military medical supply chain. As a prime contractor with no identified subcontractors, DMS Pharmaceutical Group leverages its small business status and substantial federal contracting experience—with registration in the System for Award Management since July 2001—to support recurring medical supply needs of DoD healthcare operations globally.
Quick answers
Who was awarded contract SPE2DR26FQWM1?
SPE2DR26FQWM1 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 27, 2026.
How much is contract SPE2DR26FQWM1 worth?
The government has obligated $107,125 on SPE2DR26FQWM1.
Is contract SPE2DR26FQWM1 an order under another contract?
Yes. SPE2DR26FQWM1 is a delivery order under SPE2DR25D9353, an indefinite delivery contract.
Was contract SPE2DR26FQWM1 competed?
The extent of competition for SPE2DR26FQWM1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award